Last reviewed · How we verify

NCT03637166

Acute Exposure to High Altitude on Pulmonary Artery Pressure and Right Heart Function (Echo)

Completed NA Last updated 7 January 2020
What this trial tests

NA trial testing Assessment at Low Altitude (470m above sea level) in Pulmonary Hypertension in 28 participants. Completed in 1 January 2019.

Timeline
1 July 2018
Primary endpoint
1 January 2019
1 January 2019

Quick facts

Lead sponsorUniversity of Zurich
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeprevention
Enrollment28
Start date1 July 2018
Primary completion1 January 2019
Estimated completion1 January 2019
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University of Zurich

Who can join

18 and older, any sex, with Pulmonary Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized crossover Trial in patients with Pulmonary Hypertension (PAH, CTEPH) to assess the acute response to High Altitude ("Säntis"; 2500m above sea level) on pulmonary artery pressure and right heart function (echo)

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Assessment at Low Altitude (470m above sea level)

Trials testing the same drug.

Other recruiting trials for Pulmonary Hypertension

Currently open trials in the same condition.

Other University of Zurich trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03637166.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing